TABLE 3.
The whole results of GO functional analysis.
| Ontology | ID | Description | q value | Count |
| BP | GO:0002377 | immunoglobulin production | 5.35E-06 | 14 |
| BP | GO:0002440 | production of molecular mediator of immune response | 8.19E-06 | 16 |
| BP | GO:0006910 | phagocytosis, recognition | 4.59E-05 | 9 |
| BP | GO:0006958 | complement activation, classical pathway | 0.000229 | 10 |
| BP | GO:0006956 | complement activation | 0.000229 | 11 |
| BP | GO:0050871 | positive regulation of B cell activation | 0.000229 | 10 |
| BP | GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 0.000321 | 10 |
| BP | GO:0006911 | phagocytosis, engulfment | 0.000321 | 9 |
| BP | GO:0099024 | plasma membrane invagination | 0.000527 | 9 |
| BP | GO:0050853 | B cell receptor signaling pathway | 0.00054 | 9 |
| BP | GO:0010324 | membrane invagination | 0.000714 | 9 |
| BP | GO:0006959 | humoral immune response | 0.000778 | 14 |
| BP | GO:0016064 | immunoglobulin mediated immune response | 0.000778 | 11 |
| BP | GO:0019724 | B cell mediated immunity | 0.000823 | 11 |
| BP | GO:0050864 | regulation of B cell activation | 0.000949 | 10 |
| BP | GO:0002449 | lymphocyte mediated immunity | 0.002587 | 13 |
| BP | GO:0007409 | axonogenesis | 0.002863 | 15 |
| BP | GO:0008037 | cell recognition | 0.002863 | 10 |
| BP | GO:0002429 | immune response-activating cell surface receptor signaling pathway | 0.002863 | 15 |
| BP | GO:0002757 | immune response-activating signal transduction | 0.002863 | 15 |
| BP | GO:0007411 | axon guidance | 0.004257 | 11 |
| BP | GO:0097485 | neuron projection guidance | 0.004257 | 11 |
| BP | GO:0042742 | defense response to bacterium | 0.004348 | 12 |
| BP | GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.009757 | 12 |
| BP | GO:0051249 | regulation of lymphocyte activation | 0.011431 | 14 |
| BP | GO:0002920 | regulation of humoral immune response | 0.016708 | 7 |
| BP | GO:0042113 | B cell activation | 0.040074 | 10 |
| BP | GO:0006909 | phagocytosis | 0.040074 | 11 |
| BP | GO:0050851 | antigen receptor-mediated signaling pathway | 0.043343 | 10 |
| CC | GO:0019814 | immunoglobulin complex | 1.39E-21 | 25 |
| CC | GO:0042571 | immunoglobulin complex, circulating | 1.90E-06 | 9 |
| CC | GO:0009897 | external side of plasma membrane | 4.75E-05 | 16 |
| CC | GO:0031225 | anchored component of membrane | 0.008656 | 8 |
| MF | GO:0034987 | immunoglobulin receptor binding | 6.33E-06 | 9 |
| MF | GO:0003823 | antigen binding | 0.000225 | 10 |
| MF | GO:0004252 | serine-type endopeptidase activity | 0.008426 | 8 |
| MF | GO:0033130 | acetylcholine receptor binding | 0.010056 | 3 |
| MF | GO:0008236 | serine-type peptidase activity | 0.010191 | 8 |
| MF | GO:0016825 | hydrolase activity, acting on acid phosphorus-nitrogen bonds | 0.010191 | 8 |
| MF | GO:0017171 | serine hydrolase activity | 0.010191 | 8 |
| MF | GO:0005109 | frizzled binding | 0.013552 | 4 |
| MF | GO:0008201 | heparin binding | 0.024119 | 7 |
| MF | GO:0005246 | calcium channel regulator activity | 0.024119 | 4 |
| MF | GO:0004175 | endopeptidase activity | 0.035063 | 11 |
| MF | GO:0004867 | serine-type endopeptidase inhibitor activity | 0.035063 | 5 |
| MF | GO:1901681 | sulfur compound binding | 0.037929 | 8 |